Skip to content
Search

Latest Stories

Smartphone app fares better than face-to-face appointments in obesity fight, study finds

The patients with severe obesity can lose around five per cent of their weight and the most body mass by using a smartphone app rather than attending face-to-face appointments, a new study has showed.

The app, Oviva, is now calling for the NHS to fully embrace digital as a core platform to help people living with obesity or other health conditions in post-Covid world.


In new peer-reviewed research, 169 people living with severe obesity took part in a tier 3 weight management programme for 12-16 weeks.

The programme was commissioned jointly by the NHS and a local authority in West Yorkshire and provided by digital weight management provider Oviva. Participants had a BMI of at least 40 - and were referred onto the programme by their GP.

The key findings of the study include:

  • an overwhelming majority of people (64.5%) opted to join the programme on the app, compared to 28.4 per cent who chose face-to-face participation and 7.1 per cent who opted for over the phone. This was even before Covid-19 hit
  • more than half of patients participating on the app (53%) lost five per cent of their weight. This compares to 47.9 per cent of face-to-face participants and 33 per cent of phone participants
  • app users lost the most body mass - an average of 6.1kg. Face-to-face patients lost a mean of 5.3kg, while those who took part over the phone lost 4kg
  • some three quarters of app users (74 per cent) cut their BMI by 1 unit, compared to 64 per cent of face-to-face participants and 58 per cent for those who took part over the phone.

“Here at Wakefield Council we wanted to incorporate the digital healthcare element into our weight management service as we felt it would improve accessibility and provide a tailored approach for our service users," Cllr Jacquie Speight, Wakefield Council’s Cabinet Member for Culture, Leisure and Sport.

"From our experiences we’ve found not only does it do this, it can also improve adherence and offer a level of flexibility that can only be beneficial for all involved.”

Rosemary Huntriss, who works at Oviva and has been the specialist weight-management dietitian involved in the evaluation, said: "Covid-19 has seen a switch to more people seeing their doctor and managing their conditions remotely - and the past year has shown us that the technology works, it’s convenient, and it has potential to save the NHS vast sums of money,"

“We’d like to see digital care being fully embraced as a core platform alongside face-to-face services within the NHS to support patients living with obesity or other chronic health conditions.”

NHS Digital approved, the Oviva app is available on the NHS App Library.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less